Efficacy of Epcoritamab and Glofitamab in Diffuse Large B-Cell Lymphoma episode artwork

EPISODE · May 3, 2024 · 3 MIN

Efficacy of Epcoritamab and Glofitamab in Diffuse Large B-Cell Lymphoma

from GRACEcast - Discussions with the Global Resource for Advancing Cancer Education · host cancerGRACE

Dr. Tycel Phillips examines the efficacy of two medications against diffuse large b-cell lymphoma (DLBCL)

Episode metadata supplied by the publisher feed · Published May 3, 2024

Embed this episode

NOW PLAYING

Efficacy of Epcoritamab and Glofitamab in Diffuse Large B-Cell Lymphoma

0:00 3:02

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of GRACEcast - Discussions with the Global Resource for Advancing Cancer Education?

This episode is 3 minutes long.

When was this GRACEcast - Discussions with the Global Resource for Advancing Cancer Education episode published?

This episode was published on May 3, 2024.

Can I download this GRACEcast - Discussions with the Global Resource for Advancing Cancer Education episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!